Literature DB >> 20202771

Cholangiocarcinoma: descriptive epidemiology and risk factors.

C de Martel1, M Plummer, S Franceschi.   

Abstract

In theory, the term of cholangiocarcinoma is reserved for the tumours originating from the intrahepatic bile ducts. The problems of classification of the most frequent hilar tumours and the absence of histopathological confirmation in a large percentage of cases in cancer registries from many countries show the difficulty of establishing the specific epidemiologic behaviour of intrahepatic cholangiocarcinoma (ICC). There are clearly two types of ICC: the first one is the consequence of the recurrent infection of the biliary ducts by the parasites Opisthorchis viverrini and Clonorchis sinensis, and is only seen in the areas of Southeast Asia where liver flukes are endemic. In these areas, incidence and mortality rates of ICC are extremely high. Both parasites have been classified class I carcinogens by the International Agency for Research on Cancer. The other type of ICC is a cancer much rarer but present in the whole world. Some risk factors have been well-established (chronic inflammation of biliary ducts, hepatitis, thorotrast, etc) but many patients do not have any of these factors. An increase in incidence and mortality of this second type of ICC has been seen in recent years, mostly in developed countries. There is an ongoing discussion in the literature about its authenticity and potential causes.

Entities:  

Mesh:

Year:  2010        PMID: 20202771     DOI: 10.1016/j.gcb.2010.01.008

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  14 in total

1.  Integrated mRNA and lncRNA expression profiling for exploring metastatic biomarkers of human intrahepatic cholangiocarcinoma.

Authors:  Lisheng Lv; Miaoyan Wei; Peiyi Lin; Zhisheng Chen; Peng Gong; Zhiwei Quan; Zhaohui Tang
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

2.  Differential Expression of Sonic Hedgehog Protein in Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Authors:  Redha Al-Bahrani; Seishi Nagamori; Roger Leng; Anna Petryk; Consolato Sergi
Journal:  Pathol Oncol Res       Date:  2015-03-05       Impact factor: 3.201

3.  Epidemiology and Risk Factors of Cholangiocarcinoma.

Authors:  Martha M Kirstein; Arndt Vogel
Journal:  Visc Med       Date:  2016-12-01

4.  Infection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome.

Authors:  Jordan L Plieskatt; Raksawan Deenonpoe; Jason P Mulvenna; Lutz Krause; Banchob Sripa; Jeffrey M Bethony; Paul J Brindley
Journal:  FASEB J       Date:  2013-08-07       Impact factor: 5.191

5.  Digital lesion leading to diagnosis of cholangiocarcinoma.

Authors:  Dhauna Karam; Bharat Agrawal; Chandra Mouli
Journal:  BMJ Case Rep       Date:  2017-10-04

6.  Predictive and prognostic molecular markers for cholangiocarcinoma in Han Chinese population.

Authors:  Lingqin Meng; Zhong Tian; Yong Wang; Yuan Liu; Jingang Liu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

7.  MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.

Authors:  Li-Juan Wang; Chen-Chen He; Xin Sui; Meng-Jiao Cai; Cong-Ya Zhou; Jin-Lu Ma; Lei Wu; Hao Wang; Su-Xia Han; Qing Zhu
Journal:  Oncotarget       Date:  2015-03-20

8.  Long-term trends in incidence and mortality of intrahepatic and extrahepatic bile duct cancer in Japan.

Authors:  Mai Utada; Yuko Ohno; Tomoko Tamaki; Tomotaka Sobue; Ginji Endo
Journal:  J Epidemiol       Date:  2014-03-07       Impact factor: 3.211

9.  Differential activation of diverse glutathione transferases of Clonorchis sinensis in response to the host bile and oxidative stressors.

Authors:  Young-An Bae; Do-Whan Ahn; Eung-Goo Lee; Seon-Hee Kim; Guo-Bin Cai; Insug Kang; Woon-Mok Sohn; Yoon Kong
Journal:  PLoS Negl Trop Dis       Date:  2013-05-16

10.  Prognostic significance of snail expression in hilar cholangiocarcinoma.

Authors:  Dalu Kong; Jun Liang; Rong Li; Shihai Liu; Jigang Wang; Kejun Zhang; Dong Chen
Journal:  Braz J Med Biol Res       Date:  2012-05-10       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.